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Abstract
Background: In gene expression studies a key role is played by the so called "pre-processing", a
series of steps designed to extract the signal and account for the sources of variability due to the
technology used rather than to biological differences between the RNA samples. At the moment
there is no commonly agreed gold standard pre-processing method and each researcher has the
responsibility to choose one method, incurring the risk of false positive and false negative features
arising from the particular method chosen.
Results: We propose a Bayesian calibration model that makes use of the information provided by
several pre-processing methods and we show that this model gives a better assessment of the 'true'
unknown differential expression between two conditions. We demonstrate how to estimate the
posterior distribution of the differential expression values of interest from the combined
information.
Conclusion: On simulated data and on the spike-in Latin Square dataset from Affymetrix the
Bayesian calibration model proves to have more power than each pre-processing method. Its
biological interest is demonstrated through an experimental example on publicly available data.
Introduction
In gene expression studies, one of the first steps of the sta-
tistical analysis is to quantify the signal and correct the
systematic noise through pre-processing, a series of
actions designed to extract the signal and the sources of
variability due to the technology used rather than to bio-
logical differences between the RNA samples. Many stud-
ies in the literature present the importance of pre-
processing and show how this can influence the results in
terms of differential expression (see, for example, [1] and
[2]).
However, an agreed gold standard method does not exist
and as Allison and colleagues [3] discuss in a recent paper,
researchers are torn between the different pre-processing
methods and usually end up restricting their analysis to
using only one (often the most commonly used or the
most user-friendly). A simple alternative strategy is to per-
form the analysis using two different pre-processing meth-
ods and then compare the results in terms of differential
expression, focussing attention on the genes in the inter-
section.
The former strategy is reductive while the latter relies on
the arbitrary choice of two methods and on that of consid-
ering only their intersection. Neither of these approaches
makes optimal use of all the information provided by the
pre-processing methods. As an alternative Hein and col-
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leagues [4] and Turro and colleagues [5] proposed a
method that, starting at the probe level, integrates all the
pre-processing steps and their associated uncertainty in
one single framework, and they demonstrated an increase
in power compared to the methods most used in the liter-
ature.
A different strategy is proposed in this paper, as we aim at
providing a method of analysis of a gene-expression
experiment that combines and synthesises the informa-
tion from several pre-processing methods, to obtain a bet-
ter calibrated estimate of differential expression. In the
context of microarray, many researchers have proposed
different strategies to pool together several independent
studies. In particular, they have focused attention on the
integration of each gene effect across studies [6] or on the
evaluation of the consistency of differential expression
across platforms [7]. Conlon et al. [8,9] have proposed a
different approach: they do not estimate a combined gene
effect across studies, but rather evaluate its differential
expression through a pooled binary indicator for inde-
pendent studies performed on the same platform. Their
model is formulated in a Bayesian perspective and the
posterior probability of differential expression is the
quantity of interest. Later, Scharpf et al. [10] have
extended Conlon's work to include the comparison of sev-
eral platforms and to focus attention also on genes dis-
cordant across the experiments through the estimate of
the sign of differential expression for each experiment.
These papers share a meta-analytical framework, devoting
their interest to synthesise several independent studies. In
a different perspective Yang et al. [11] proposed a model
for combining several measures of differential expression
on the same experiment into an index; then they ranked
the genes accordingly, using a permutation based test to
select the differentially expressed genes. Similarly, we
work on a single experiment, but concentrate on combin-
ing several pre-processing techniques; thus we adopt a
measurement error perspective assuming for each gene a
latent (unmeasured) 'true' differential expression and for
each pre-processing method: (i) a measured value that
departs from it (bias) and (ii) a variance component.
Modelling measurement error is common practice in epi-
demiology, where errors in the recording of explanatory
variables are a frequent problem that has to be taken into
account during the statistical analysis (see for example
[12-15]); the formulation in a Bayesian framework has
been discussed in the early 1990s by Thomas et al. [16],
Richardson and Gilks [17,18] and Richardson [19] among
others, placing particular emphasis on the way their
approach propagates coherently all sources of uncertainty
in the data onto the estimation of the parameters of inter-
est.
We follow Richardson and Gilks and specify a Bayesian
calibration model for assessing differential expression in
Affymetrix microarray, which combines the information
from several pre-processing techniques and it is imple-
mented using the freely available software WinBUGS [20].
The performance of the combined model for assessing dif-
ferential expression is compared with the performance of
the equivalent Bayesian model on each single pre-process-
ing method using simulated data and the Latin square
data set provided by Affymetrix [21]. The combined
method is shown to have better operating characteristics;
its biological interest is discussed on an experiment pub-
licly available to evaluate the effect of High Fat Diet versus
Normal Fat Diet in mice adipose tissue.
Results
Bayesian calibration model
A combined model for different pre-processing methods
is characterised by two measurement error components:
(i) a measure of the bias from the 'true' differential expres-
sion, that can assume additive or multiplicative form and
(ii) a measure of variability around the mean gene expres-
sion.
When the bias is multiplicative, following the general for-
mulation given in [22], we model the observed log expres-
sion value for gene g = 1, ... G, pre-processing method j =
1, ..., J, condition k = 1, 2 and replicate r = 1, ..., R as a Nor-
mal distribution:
The parameter αgj represents the global gene expression
that is specific to the gene g  and the pre-processing
method j, whereas δg is the 'true' (unknown) differential
expression that we would like to capture for gene g. The
method specific coefficient φj quantifies the multiplicative
bias of the method with respect to the latent quantity δg.
When the bias is additive (1) becomes:
where ϕj is replaced by ξj.
We empirically investigated the performance of additive
and multiplicative bias on two datasets we use in the rest
of the paper (see Materials and Methods for the descrip-
tion of the datasets). A pairwise comparison of the differ-
ential expression for the J methods is presented in Figure
1 and 2 of Additional file 1 and shows that the data are
not lying on the diagonal, but are characterised by a slope
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different from 1. This suggests the presence of a multipli-
cative bias, while in general there is no evidence of a shift
in the differential expression that would suggest the pres-
ence of an additive bias. For this reason, in the rest of the
paper we consider the multiplicative bias model (1) and
call ϕj the relative bias as it indicates the inflation or defla-
tion factor of the 'true' differential expression characteris-
tic of a particular pre-processing method. Other details
about the investigation we carried out on the two datasets
are presented in the Discussion. In (1), for each gene, pre-
processing and condition, the variance   is the result
of a gene and condition specific component   and an
exponential error term specific to the pre-processing
method and to the condition:
The exponential component is allowed to depend on the
global expression of the gene   as it
has often been noted that even after log transformation,
the variability of the expression of a gene can be affected
by its level of expression (see for example [23]). The use
of a second order polynomial offers considerable flexibil-
ity yet involving a limited number of parameters; a simpli-
fied version of equation (3) can be formulated where the
coefficients λ2jk and λ3jk are equal to 0, so that the expo-
nential component becomes independent from the
expression of the gene. Following [22] we assign a hierar-
chical structure on the probeset and condition specific
component, to borrow strength from the entire set of
genes:
To complete the model we specify weakly informative
prior distributions for all the remaining parameters as we
do not have specific prior information available on these,
so they will be informed by the data. To be precise, we
specify a centred Normal distribution with large variance
(105) on αgj and δg. The relative bias coefficients are mod-
elled as ϕj ~logN (0, 105) independently for j = 1, ..., J,
imposing the identifiability constraint that ∏ ϕj = 1.
The coefficients for the exponential component in (3) are
assumed independent and to follow Normal distributions
λ1jk ~N (0, 105), λ2jk ~N (0, 105), λ3jk ~N (0, 105), so that
the function can model a wide variety of trends. As iden-
tifiability constraint, we impose that the sum of the exper-
imental parameters in (3) over the three pre-processing
methods is equal to 0 (Σj λ1jk = 0, Σj λ2jk = 0, Σj λ3jk = 0). We
use the exponential parametrization to ensure positivity
of (3). Finally, ak  ~Ga(0.01, 0.01) and we model
, where   is the sample var-
iance for gene g and condition k; this choice ensures that
the posterior distributions of ak and bk are proper and well
adapted to the scale of the data, as justified in [24].
Models (1) and (3) allow the borrowing of information
across genes to estimate ϕj and λjk, and across methods to
estimate δg and  . The hierarchical model specified by
(1), (3), (4) and the prior distributions are estimated
using an MCMC algorithm coded in WinBUGS [20] to
simulate the prior/posterior distribution of all unknown
parameters. More details can be found in the Materials
and Methods section and in Additional file 1.
Tail posterior probability
For each gene we are interested in testing the hypothesis
that the differential expression effect δg is different from 0:
and a variety of decision rules based on the output of the
hierarchical model can be constructed. We chose to use
the tail posterior probability statistic introduced in [24] to
measure the strength of the evidence against H0. This
method considers a standardisation of the differential
expression measure   where wg is a pooled meas-
ure of variability of δg:
Here R is the number of replicates for each condition and
J is the number of pre-processing methods considered. A
value of zg is obtained at each iteration of the MCMC sim-
ulation after convergence is reached and the tail posterior
probability statistic is then defined as follows:
p(zg; zα) = P(|zg| > zα | yg)( 5 )
where yg denotes all the data available for gene g and zα is
the α quantile of the standard normal distribution (usu-
ally α = 0.05 and consequently zα = 1.96). As discussed in
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[24] the histogram of p(zg; 1.96) is characterised by a local
peak on the right tail in the presence of differentially
expressed genes; this peak can be used to define a reason-
able cut off for the differential expression (see the section
that describes the results on the experimental data for an
illustrative example).
The tail posterior probability statistic can be loosely inter-
preted as a Bayesian analogy of the t-test. It makes full use
of the Bayesian output being a function of the differential
expression (δg) and of the variability  , is
easy to use and was shown to have good statistical prop-
erties (see [24] for more details).
Assessing the fit of the model
Before using the calibration model as specified in (1)–(4)
to infer differentially expressed genes, it is important to
assess its ability to capture the sources of variability of the
pre-processing methods, and in particular whether the
parametrisation used in (3) is appropriate. One of the
added benefits of working in a Bayesian framework is the
ability to perform model checks by means of the predic-
tive distribution of the parameters of interest. We use
Mixed Posterior Predictive checks [25,26], applied on
gene expression data by Lewin et al. [22,27] and focus
attention on checking the gene specific variance, charac-
terised by a hierarchical structure as described in equa-
tions (3) and (4). For each method, we compare the
observed sample variance, calculated for the expression
values, and the variance of the predicted expression values
of each gene under the model using an empirical p-value.
Under the null hypothesis of the model being true, the
distribution of the p-values should be approximatively
uniform, while a poor model fit is indicated by departure
from uniformity in the plot, suggesting a systematic differ-
ence between the observed values and the predicted ones
(see Additional file 1 and [22,27] for more details).
The Mixed Posterior Predictive check is characterised by a
certain degree of subjectivity as the researcher has to visu-
ally assess the fit of the model through a plot. Comple-
mentary to this, we also provide a quantitative measure of
model fit, enabling a more direct comparison between
different models by means of the Deviance Information
Criterion (DIC) [28]. This index has been proposed as an
extension of the Akaike Information Criterion when deal-
ing with Bayesian hierarchical models. It is defined as a
function of the deviance of the model and of the effective
number of parameters included:
DIC = Eθ [D(θ)] + pD
where Eθ [D(θ)] is the posterior mean of the deviance of
the model and pD is the effective number of parameters.
When comparing two or more models, the one character-
ised by the smallest DIC shows the best fit to the data in
hand.
Performance on simulated data
To first evaluate the benefits of using a model that com-
bines several pre-processing methods we simulated log
expression values for 1000 genes, 5 pre-processing and 2
conditions, following the approach described in the sec-
tion Materials and Methods. We set 200 genes as differen-
tially expressed and the remaining 800 genes as not
differentially expressed. We considered a simplification of
equation (3) assuming (i) the same variance for the two
conditions   and (ii) the exponential compo-
nent as independent from the global gene expression (λ2jk
= 0, λ3jk = 0). This does not detract from evaluating the
comparative performance of the calibration model versus
each method. To evaluate the consistency of our results we
repeated the simulation 10 times and averaged the results.
The typical behavior of the combined method compared
to each single pre-processing is presented in Figure 1: the
ROC curve averaged over the 10 runs shows a greater sen-
sitivity and specificity for the model that combines the
five pre-processing approaches.
Ranking the pre-processing methods based on the ROC
curve, Method 3, characterised by large relative bias and
small variability (in the simulation set up ϕ3 = 2 and
exp(λ3) = 0.5), shows the best performance, while on the
other end, Method 4, characterised by small relative bias
and high variability (in the simulation set up ϕ4 = 0.5 and
exp(λ4) = 2), shows the worst ROC curve. Note that the
'reference' method, characterised by exp(λ1) = 1 and ϕ1 =
1 shows an average specificity and sensitivity.
The influence of the relative bias coefficient ϕj can be eval-
uated when doing pairwise comparisons of methods with
the same variability (Method 2 vs Method 3 and Method
4 vs Method 5). If it is greater than 1 (Method 3 and
Method 5), the corresponding pre-processing methods are
assumed to magnify the 'true' differential expression. This
results in a stronger signal and consequently in a greater
ability to discern true positives and true negatives.
On the other hand, comparing methods characterised by
the same value for the relative bias coefficient (Method 2
vs Method 4 and Method 3 vs Method 5) the difference in
their performance is explained by the exponential compo-
nent of variability exp(λj): a low value (Method 2 and
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Method 3) results in a higher precision of the estimates,
enhancing the performance of the method in terms of spe-
cificity and sensitivity. Table 1 presents the operating char-
acteristics for all the pre-processing methods and for the
combined strategy. As we set 200 genes as differentially
expressed in the simulation scenario, we consider the first
200 genes ranked according to the tail posterior probabil-
ity (5) and evaluate the number of False Positives (FP),
False Negatives (FN), True Positives (TP) and True Nega-
tives (TN). The results are averaged over 10 repeats. The
combined method is able to detect the maximum number
of truly differentially expressed genes (179) and is charac-
terised by only the 2.6% of False Positives. As already
pointed out, the methods with a ϕj > 1 (Method 3 and
Method 5) have a higher signal, leading to a better per-
formance, characterised by a small percentage of False
Positives and False Negatives.
Latin square data set
We applied the model presented in (1), (3) and (4) to the
10621 probesets present in the Latin square data set
(experimental condition 2 versus 1), where only 64 genes
are truly differentially expressed. The p-values histograms for
the two conditions obtained from the Posterior Predictive
checks are presented in the upper plots of Figure 2 and are
characterised by a uniform behavior, suggesting a good
model fit to the data. As a point of comparison we ran the
simplified model characterised by λ2jk  =  λ3jk  = 0 and
present the corresponding Posterior Predictive checks in
the lower plots of Figure 2. These plots show a clear devi-
ation from uniformity with an over representation of
small and large p-values, in particular for condition 1, sug-
gesting a lack of flexibility of the simpler model to account
for all the variability present in the data. Hence we retain
the variance model in (3) for our analysis.
Table 2 presents a synthesis of the results for the com-
bined model and for each single pre-processing method.
We evaluated the operating characteristics of each method
based on the first 64 probesets ranked accordingly to their
tail posterior probability. The combined method shows
an improvement in sensitivity and specificity, even if
modest: out of the first 64 ranked probesets only 12 are
false positives, while the number increases to 14 for RMA
ROC curve for the simulation study Figure 1
ROC curve for the simulation study. The plot shows the 
ROC curve for the Bayesian models averaged over the 10 
simulated dataset: in each case we simulated 200 differentially 
expressed and 800 not differentially expressed genes. We 
have implemented the models either combining the five pre-
processing methods together (solid line) or analysing each 
one separately and ranked the tail posterior probability of 
differential expression. The ROC curve for the combined 
model is above that of each pre-processing method, high-
lighting the benefit of using a combined model in terms of 
specificity and sensitivity.
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ROC: Average of 10 Simulations
FP/(FP+TN)
T
P
/
(
T
P
+
F
N
)
Combined
Method 1 (e
λ =1,φ=1)
Method 2 (e
λ =0.5,φ=0.5)
Method 3 (e
λ =0.5,φ=2)
Method 4 (e
λ =2,φ=0.5)
Method 5 (e
λ =2,φ=2)
Table 1: Operating characteristics for simulated data
DE Non DE FP (%) TN (%) TP (%) FN (%) sd
Combined 200 800 21 (2.6) 779 (97.4) 179 (89.5) 21 (10.5) 5.0
Method 1 (exp(λ) = 1, ϕ = 1) 200 800 61 (7.6) 739 (92.4) 139 (69.5) 61 (30.5) 5.5
Method 2 (exp(λ) = 0.5, ϕ = 0.5) 200 800 80 (10.0) 720 (90.0) 120 (60.0) 80 (40.0) 4.8
Method 3 (exp(λ) = 0.5, ϕ = 2) 200 800 26 (3.2) 774 (96.8) 174 (87.0) 26 (13.0) 4.1
Method 4 (exp(λ) = 2, ϕ = 0.5) 200 800 122 (15.2) 678 (84.8) 78 (49.0) 122 (61.0) 3.3
Method 5 (exp(λ) = 2, ϕ = 2) 200 800 45 (5.6) 755 (94.4) 155 (77.5) 45 (22.5) 5.8
The table presents the number of False Positives (FP), True Negatives (TN), True Positives (TP) and False Negatives (FN) in the first 200 genes 
ranked accordingly to their tail posterior probability. Note that FP = FN since the size of the list of differentially expressed genes is equal to the 
number of true positives. The combined method shows the smallest number of FP and FN. Out of the 5 pre-processing methods, the one 
characterised by a relative bias parameter ϕj > 1 and a variability parameter exp(λj) < 1 (Method 3) shows the best performance, due to the 
combination of high signal and low variability around the mean gene expression. The standard deviation calculated on the 10 runs is also reported 
in the table. Note that as FP, FN, TP and TN are a linear function of each other given a fixed sum, the standard deviation is the same for the 4 
variables.BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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and then jumps to 23 and 31 for MAS5 and dChip respec-
tively. When the gene list size increases, the performance
for the different methods tends to converge.
Table 3 reports the posterior mean of the relative bias
effect ϕj together with the 95% credibility interval. We see
that MAS5 and RMA are characterised by a mean value
greater than 1, meaning that they inflate the estimate δg
relative to dChip.
Mixed Posterior Predictive checks for the Latin square data set Figure 2
Mixed Posterior Predictive checks for the Latin square data set. The upper plots present the distribution of the 
mixed predictive p-values for the two conditions fitting the calibration model presented in (3) which assumes that the variabil-
ity is specified by a polynomial function of the level of expression. They show a uniform behavior for both conditions, indicating 
an excellent model fit. The values for λ1jk, λ2jk and λ3jk are presented in Table 6 in Additional file 1. The bottom plots present 
the distribution of the p-values for the two conditions after fitting the simpler model assuming λ2jk = λ3jk = 0. They show a lack 
of fit, in particular for condition 1, indicating that the simple variance model is not appropriate for this dataset.
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Similar results in terms of parameter estimates and per-
formance are obtained for additional pairwise compari-
sons on this dataset, as presented in Tables 1, 2, 3 of
Additional file 1. These comparisons have been selected to
represent a wide spectrum of differential expression and
to show that the results are consistent across different
experiments.
Biological example: High Fat Diet versus Normal Fat Diet 
in mice adipose tissue
We applied the model presented in (1), (3) and (4) to the
12488 probesets in the experiment to study the effect of
high fat diet (HFD) versus normal fat diet (NFD) on mice
adipose tissue, as part of the DGAP project [29]). As for
the Latin Square data set the Mixed Posterior Predictive
checks show a good fit, while the simpler model with λ2jk
= λ3jk = 0 is not adequate (see Figure 3).
We use the histogram of the tail posterior probability to
identify a reasonable cut off for calling a gene differen-
tially expressed. Contrary to what happens for each single
pre-processing method, the histogram of the tail posterior
probability for the combined model shows a local peak
on the right tail of the distribution (see Figure 3 of Addi-
tional file 1), indicating more evidence of differential
expression. As suggested in [24], we select a high cut off
value, in our case equal to 0.98, corresponding to the local
peak on the combined distribution, and obtained a list of
292 'top' probesets classified as differentially expressed by
the combined method. If we fixed the same cut off on the
tail posterior probability for each pre-processing method,
we would obtain substantially smaller lists with only 20
probesets classified as differentially expressed by MAS5,
32 by RMA and 41 by dChip. Selecting a standard thresh-
old such as 0.95 gives similar results in term of the size of
the lists: the combined one is the largest, while MAS5 is
characterised by the smallest. This highlights the typical
gain of confidence provided by the combined analysis:
many more probesets have high posterior probability of
being differentially expressed in the combined model
than if we proceeded for each method separately. In order
to perform a further comparison between the methods we
also consider the first 292 probesets ranked according to
the tail posterior probability for each single method. Note
that in doing so we lower the cut off on the tail posterior
probability scale for each method (0.78 for MAS5, 0.79
for RMA and 0.83 for dChip), introducing more noise in
the list.
Figure 4 shows the Venn diagram for the three single
methods and the combined model. All the 46 probesets in
the intersection of the three methods are included in the
list of 'top' probesets by the combined model. Addition-
ally, there are 61 probesets that are only found in the com-
bined list and are of particular interest. These are
characterised: (1) by a probability greater than 0.5 for at
least two methods (usually RMA and dChip, or some-
times, MAS5 and one of the other two), (2) by a substan-
tial different variability between the two conditions and a
relatively small fold change (see Figure 4 in Additional file
1 for a boxplot of some of the 61 probesets). Considering
each pre-processing method separately, these fold changes
do not reach the top of the list, but the combined strategy
increases their significance, by synthesising the evidence
from the three pre-processing methods. This suggests that
combining several pre-processing methods leads to larger
lists of genes than considering the intersection of lists
obtained for each method, as more information coming
from different sources is taken into account.
Figure 5 presents the plot of the log fold change versus the
posterior probability (volcano plot) for the combined
model and for each pre-processing method considered
separately. The 292 probesets called by the combined
method are highlighted in red and the 61 selected only by
the combined approach are highlighted in green. The 292
probesets are placed in the upper half of the plot for RMA
and dChip, being characterised by values of the posterior
probability far from 0. This indicates that in general when
a gene shows some evidence of differential expression for
the two methods with smaller variability, the combined
Table 2: Operating characteristics for Latin Square dataset
First 64 ranked probesets
FP (%) TN (%) TP (%) FN (%)
Combined 12 (0.1) 10545 (99.9) 52 (81.3) 12 (18.7)
MAS5 23 (0.2) 10534 (99.8) 41 (64.1) 23 (35.9)
RMA 14 (0.1) 10543 (99.9) 50 (78.1) 14 (21.9)
dChip 31 (0.4) 10526 (99.6) 33 (51.6) 31 (48.4)
The table presents the operating characteristics of the combined 
method and of each pre-processing method on the first 64 probesets 
ranked accordingly to their tail posterior probability. The combined 
strategy is more able to recognize true positives and true negatives 
than each single method. Note that FP = FN since the size of the list of 
differentially expressed probesets is equal to the number of true 
positives.
Table 3: Posterior mean and credibility interval for ϕj
Latin Square data set Real Experiment: HFD vs NFD
E(ϕj | y) CI95% E(ϕj | y) CI95%
MAS5 1.382 [1.345–1.417] 1.449 [1.438–1.462]
RMA 1.144 [1.124–1.165] 1.064 [1.056–1.074]
dChip 0.632 [0.623–0.644] 0.648 [0.643–0.653]
Posterior mean and 95% credibility intervals for the relative bias effect 
ϕj in the Latin Square data set (left) and in the experimental data 
analysis that compares the effect of high fat diet (HFD) and normal fat 
diet (NFD) on adipose tissue of mice (right).BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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approach strengthens this evidence and places these
probesets at the top of the list of differential expression.
MAS5 is the method that contributes the least to the com-
bined output, being associated with the largest variability.
For this reason, some probesets with a tail posterior prob-
ability smaller than 0.5 for MAS5 can still be found at the
top of the list for the combined method, if their posterior
probability values for RMA and dChip are large enough.
On the other hand, MAS5 shows the largest ϕj effect (pre-
sented on the right hand side of Table 3); thus, as already
observed in the previous sections, the method is charac-
terised by a larger signal that may provide additional
information on the differential expression. This results in
7 probesets called as differentially expressed only by
MAS5 that are placed in the top list for the combined
method. These probesets would not be selected as differ-
Mixed Posterior Predictive checks for the HFD example Figure 3
Mixed Posterior Predictive checks for the HFD example. The upper plots present the distribution of the p-values for 
the two conditions (HFD and NFD) after fitting the calibration model presented in (3) which assumes a polynomial function of 
the level of expression. They show a uniform behavior for both conditions, indicating good model fit. The values for λ1jk, λ2jk 
and λ3jk are presented in Table 7 of Additional file 1. The bottom plots present the distribution of the p-values for the two con-
ditions (HFD and NFD) fitting the simpler calibration model assuming λ2jk = 0 and λ3jk = 0. The histograms indicate the pres-
ence of two peaks corresponding to very small and very large p-values, suggesting a poor fit.
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entially expressed when considering only RMA and
dChip.
The contribution of MAS5 to the combined output has
been further investigated by implementing a version of
our model that combines only RMA and dChip and com-
paring the results. In general, combining only these two
methods results in 205 probesets classified as differen-
tially expressed for a cut off of 0.98, again chosen on the
basis of the local peaks on the tail posterior probability
histogram (see Figure 5 of Additional file 1). Out of these,
163 are in common with the model combining the 3
methods and 42 are specific to the two-methods calibra-
tion model. In the three-methods combined model, these
42 probesets are either (i) borderline or (ii) far from the
top of the list, characterised by high tail posterior proba-
bility for only one method. This shows that for some
probesets there remains a non negligible source of uncer-
tainty when only two methods are considered. When a
third method is included, evidence in favor of the null
hypothesis of no differential expression is added and
these probesets are not classified as significant anymore.
Moreover, including an additional method in the synthe-
sis results in 129 new probesets called differentially
expressed: these probesets are borderline in the model
with only two methods, characterised by a posterior prob-
ability ranging between 0.81 and 0.96; for them the evi-
dence against H0 is thus strengthened by the introduction
of MAS5 in the model.
Table 4 presents the number of annotated genes in the list
of the first 292 ranked probesets for the model combining
the three pre-processing methods and for each single one.
For the combined method the most represented biologi-
cal processes are the metabolic ones, functions associated
with the response of the body to a change in the diet. The
number of genes involved in cellular metabolism, is 105 for
the combined method, 70 for dChip, 87 for MAS5 and 88
for RMA. Similarly the number of genes involved in pri-
mary metabolism or macromolecular metabolism is
larger for the combined method than for each pre-
processing one.
We compared the annotations of each method and of the
combined one using the Fisher exact test [30] for the list
of differentially expressed genes against the remaining
genes in the array. We found that the combined method
enriches 7 additional biological processes compared to
those found by RMA, 5 additional biological processes
and 3 additional cellular components compared to those
found by MAS5 and 3 additional biological processes
compared to those found by dChip.
The most represented KEGG pathways are related to
immune response and oxidation (Antigen processing and
presentation, MAPK signalling pathway, PPAR signaling path-
way), biological regulators of physiological functions as
energy metabolism, insulin action, immunity and inflam-
mation and known from the literature to be associated
with high fat diet (see [31] and [32]). Out of the KEGG
pathways only the Insulin signaling pathway is enriched for
the combined method with respect to the annotations of
each single method.
Discussion
The Bayesian calibration model that we propose makes
use of the dependence between the results of the pre-
processing methods and in doing so it gives a better
assessment of the 'true' unknown differential expression
between the conditions. Note that our calibration model
relies on having generally applicable pre-processing meth-
ods for single arrays, and it is not aimed at replacing any
of these as its applicability is limited to differential expres-
sion assessment, but it demonstrates that when dealing
with several pre-processing methods, there is a good alter-
native to choosing just one for assessing differential
expression. By using natural assumptions on the structure
of the measurement errors it enables (i) to borrow infor-
Venn diagram Figure 4
Venn diagram. The figure shows the number of probesets 
in the top list of 292 features for each method according to 
their relation with all the other methods. The number of 
probesets in common between 1,2 or all the methods and 
the combined one are shown in parenthesis. For instance, in 
the intersection of MAS5 and dChip there are 7 probesets; 
out of them 6 (shown in parenthesis) are in common also 
with the combined method.BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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mation across the genes to estimate the method specific
operational characteristics (λj, ϕj) and (ii) to borrow infor-
mation across the methods to estimate a measure of dif-
ferential expression (δg) and a component of variability
 specific to each probeset.
The reader should bear in mind that for the sake of clarity,
the simulation has been set to represent a wide range of
pre-processing methods, thus large differences between
the parameters λj and ϕj for the 5 methods included were
set. Note that when the bias is larger than 1, the signal is
inflated, hence conditions are more favorable to detect
differential expression. This does not mean that, paradox-
ically, the best pre-processing method is always character-
ised by the largest bias as the variability plays also a key
role. The method that shows the best performance in
terms of sensitivity and specificity achieves a balance
between degree of inflation and variability. A realistic sce-
nario is presented for the Latin Square dataset in Table 2
() σ g
2
Volcano plot for the HFD experiment Figure 5
Volcano plot for the HFD experiment. The plot shows the different behavior of the pre-processing methods: dChip has a 
small variability resulting in a compact volcano plot, while MAS5 is characterised by a large variability that causes some 
probesets with very different values of the log fold change to have very similar posterior probability. The combined method 
shows a distribution close to dChip. The 292 probesets called differentially expressed by the combined model using a cut off of 
0.98 on the tail posterior probability scale are highlighted in red in all the plots; the 61 probesets selected only by the com-
bined method are highlighted in green in all the plots.
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and 3 where RMA shows the best performance and is char-
acterised by a relative bias ϕj = 1.14 larger than dChip, but
smaller than MAS5.
The inflation/deflation of differential expression found by
the different methods could be related to the different
steps that build each pre-processing method. MAS5 is the
only method that normalises each array separately, while
the internal normalisation of RMA and dChip forces the
distribution to be the same between arrays and between
conditions. This tends to reduce the width of the distribu-
tion, and can impact on the differential expression, lead-
ing to some shrinkage. Moreover, it has been shown in the
literature that methods that subtract the mismatch are
subject to higher variability in the expression ([33] and
[34]). This finds confirmation in our examples as MAS5 is
the only method included in the model that considers the
mismatch correction and it exhibits the largest variability
within biological replicates.
We want to stress the importance of having a way to assess
whether the formulation of the synthetic model is an ade-
quate representation of what is common and specific to
the different methods. Bayesian model checks based on
prediction allow the comparison of the observed data and
the 'predicted' data under the model with respect to any
feature of interest. We believe that the Mixed Posterior
Predictive checks that we considered are effective for
model criticism. They have the advantage of calculating a
measure of discrepancy (the empirical p-value) for each
gene that can be easily displayed through a histogram. On
the Latin square and the experimental data we chose a
flexible and realistic model, that allows a relation between
the expression   and the variance  . Comparing
this formulation to a simpler version which assumes no
relation between variability and level of expression by
means of the Mixed Posterior Predictive checks, we clearly
see a better fit for the more flexible model, which indicates
that a variance parametrisation linked to the level of
expression is better suited to the complexity of experimen-
tal data.
We have also calculated the Deviation Information Crite-
ria (DIC) for each model and reached the same conclu-
sions (see Tables 4, 5 in Additional file 1). We recommend
that researchers use these tools to check the fit of the
model to the data in hand and to compare different for-
mulation. If necessary possible model extensions that
might be appropriate to particular cases will need to be
formulated and investigated. As the model proposed is
designed for differential expression studies it seems rea-
sonable that the bias parameter is proportional to the dif-
ferential expression index δg, but independent of the
expression level αgj. The level of expression is taken into
account through the model of the variance σgjk for each
pre-processing method. Nevertheless, on the Latin Square
dataset we investigated the performance of a model where
the bias is a polynomial function of the gene expression
level (ϕ1j +  ). It shows a worse fit than the model
with only one bias parameter ϕj, when considering both
Mixed Posterior Predictive checks and the Deviance Infor-
mation Criteria. Figure 6 of Additional file 1 shows the
histogram for the Mixed Posterior Predictive check and
Table 4 of Additional file 1 presents the Deviance Infor-
mation Criteria for the extended model.
As already pointed out in the Results section, we have car-
ried out an empirical investigation of the relative perform-
ance of the multiplicative bias model presented in (1) and
of the additive bias model presented in (2). The pairwise
comparison of the differential expression for the J meth-
ods considered supports the multiplicative bias formula-
tion (Figure 1 and 2 of Additional file 1). In addition we
reported the Deviance Information Criteria (DIC) for the
Latin Square dataset in Table 4 and for the High Fat Diet
dataset in Table 5 of Additional file 1. For both experi-
ments, the DIC confirms the worst fit of the additive bias
model.
We showed that combining several pre-processing meth-
ods is a way of including more information about the dif-
ferential expression and that this improves the
() yg σ gk
2
φ2jg y
Table 4: Annotation for differentially expressed genes
First 292 genes with the largest posterior probability
Combined Model MAS5 RMA dChip
Biological Processes 181 146 171 168
Molecular Functions 193 154 180 173
Cellular Components 179 145 173 169
KEGG pathways 223 182 215 205
The table presents the number of differentially expressed genes 
annotated by GO or KEGG considering the first 292 probesets with 
the largest tail posterior probability for each method and for the 
combined one. The most represented KEGG pathways are mainly 
related to immune response and oxidation (Antigen processing and 
presentation, MAPK signalling pathway, PPAR signaling pathway). For 
these pathways the number of genes found by the combined method 
is always larger than the one found by each pre-processing method. 
Moreover the combined model also calls 6 genes that are involved in 
the Insulin signalling pathway, specifically related to diabetes, one of the 
diseases recently highlighted to be associated with high fat diet in mice 
(see for example [45] and [46]). The same pathway is present with 
only 3 genes in MAS5 and with 2 genes in RMA and dChip.BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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performance against each single method. We illustrated
this using three commonly used pre-processing methods
for Affymetrix chips, but we want to point out that our
approach is generic in nature and that other pre-process-
ing could be added or substituted instead of the three con-
sidered, as may be deemed appropriate by the analyst. We
have carried out a limited investigation where we found
that (i) including gcRMA [33] instead of RMA improves
slightly the performance of the combining method, and
(ii) including the vsn method [35] as expected alters the
estimated parameters for the variability as vsn corrects for
the dependence between the expression level and the var-
iability, so the posterior estimates of λ2jk and λ3jk are very
close to 0.
Further extensions
The model proposed is designed for studies where the pri-
mary interest is the estimate of differential expression.
Even if this is not the focus of the present paper, we want
to point out that our methodology could be adapted to
deal with studies where the interest is the quantification
of the signal. Depending on the pre-processing methods,
calibration models for quantifying the gene expression
level would include multiplicative or additive bias, which
might be a certain functions of the expression level. Our
approach is also applicable to experiments where more
than two conditions are included (see Bochkina and Rich-
ardson [24] for the methodology related to Bayesian hier-
archical models for multiclass studies). Other extensions
could be of interest: instead of returning a measure of dif-
ferential expression for each probeset, the model could be
modified to obtain a measure for each gene, adding a new
component for estimating the variability between
probesets mapping on the same gene. Moreover, the
approach could easily be adapted to deal with data com-
ing from different types of chips (e.g. Agilent, Illumina).
Conclusion
This paper presents a Bayesian calibration model to syn-
thesise information from several pre-processing methods.
It is framed in a measurement error perspective, where
each method is assumed to produce a biased measure of
the latent true variable of interest. We specified the model
for Affymetrix chips and focussed attention on differential
expression studies, but we pointed out that the model is a
methodological contribution and that our approach is
applicable to a wide range of data types and experimental
contrasts.
Methods
Simulated data
To test the performance of our method we simulated log
expression values for 1000 genes, two conditions and five
pre-processing methods from the model previously
described, and extracted 5 replicates for each combination
of condition and pre-processing (r = 1, ..., 5). We specified
200 differentially expressed genes characterised by a log
expression ,  with  k =
1, 2, while for the remaining 800 genes the log expressions
for both conditions came from the same distribution:
. The parameters for simulating the dis-
tributions of αgj ~N (6.79, 4.77) and δg ~N (0, 0.25) were
obtained from experimental data we have analysed [36];
the model on the variance   is presented in equation
(3) with (λ2jk = 0, λ3jk = 0) and we assume the same vari-
ance for the two conditions  , obtained from
experimental data, where the mean is 0.03 and the distri-
bution can be summarised by the following quartiles:
0.02, 0.04, 0.09 and 0.15.
The 5 pre-processing methods are described in table 7:
We assume that the first method is the 'reference', being
characterised by exp(λ1) = 1 and ϕ1 = 1. Method 2 and
Method 4 have a smaller relative bias (ϕ2 = ϕ4 = 0.5), while
that of Method 3 and Method 5 is larger (ϕ3 = ϕ5 = 2);
Method 2 and Method 3 have a variability smaller than 1
(exp(λ2) = exp(λ3) = 0.5) while that of Method 4 and
Method 5 is larger (exp(λ4) = exp(λ5) = 2).
yN gjkr gj
k
gj g j ~( () , ) αδ φ σ +− × 1 1
2
2
yN gjkr gj gj ~( , ) ασ
2
σ gjk
2
() σσ gj gj 1
2
2
2 ≡
Table 5: Performance of simulated data on ϕ and λ
E(λj | y) [CI95%] E(ϕj | y) [CI95%] sd (λj)s d  ( ϕj)
Method 1 (λ = 1, ϕ = 1) 1.0 [1.0-1.0] 1.0 [1.0-1.0] n.a. n.a.
Method 2 (λ = 0.5, ϕ = 0.5) 0.5 [0.49–0.51] 0.5 [0.49–0.51] 0.03 0.04
Method 3 (λ = 0.5, ϕ = 2) 0.50 [0.49–0.51] 2.0 [1.97–2.04] 0.04 0.05
Method 4 (λ = 2, ϕ = 0.5) 2.0 [1.96–2.07] 0.5 [0.48–0.51] 0.06 0.04
Method 5 (λ = 2, ϕ = 2) 2.0 [1.97–2.04] 2 [1.99–2.03] 0.05 0.03
The table reports the posterior mean with the 95% credibility interval for the measurement error parameters, together with the true values set in 
the simulation. For all the parameters, the posterior mean coincides with the true value and is characterised by a small variability around it. The 
values are averaged over 10 runs. The empirical standard deviation over the 10 runs is also reported in the table. Note that the stardard deviation 
is not available for Method 1 as it is assumed to be the reference (λ = 1, ϕ = 1).BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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We used an MCMC algorithm with two chains to estimate
the parameters of interest (we checked convergence for
10000 iterations and then extracted a sample of 1000 iter-
ations so that the MC error was smaller that the 5% of the
sample standard deviation, as recommended).
To evaluate the consistency of our results we repeated the
simulation process 10 times and performed our Bayesian
analysis for each run. The model estimates well the values
of the parameters λ and ϕ (see Table 5 for their posterior
mean and 95% credibility intervals; see Figures 7 and 8 of
Additional file 1 for the associated posterior density
plots).
As a point of comparison we also ran the model separately
for each pre-processing method and compared the per-
formance of both combined and single pre-processing
methods in terms of sensitivity and specificity (see the
results on simulated data).
Spike-in example: Latin Square Affymetrix data
We tested our method by means of the Affymetrix Latin
Square data set [21]. The array used is human Hgu133a
and contains 22300 probesets. There are 14 experimental
conditions and each has 3 replicates. We considered the
experimental condition 2 versus 1 and the 42 spike-in
probesets indicated by Affymetrix plus the 22 new spike-
in probesets proposed by McGee et al. [37]. The ratio of
the concentrations is 2:1 for 60 spike-in probesets and 0
for the remaining 4. Among the remaining 22236
probesets we extracted only the ones present in at least
one condition, evaluated using the present/absent call
included in the Affy R package http://www.r-project.org
and obtained 10621 probesets.
We focused attention on the three most used pre-process-
ing methods : MAS5 [38], RMA [39] and dChip [40].
There are many versions of each of them, but we consid-
ered the default ones for MAS5 and RMA and the one
obtained by the expresso function for dChip. All are pro-
vided by the Bioconductor project [41]. The differences in
the three methods are described in Table 6.
We ran the combined model, but also treated separately
each pre-processing method. Again we performed the
MCMC estimation with two chains (we checked conver-
gence for 10000 iterations and then extracted a sample of
1000 iterations, characterised by a MC error smaller than
5% of the sample standard deviation, as recommended).
The MCMC simulation of the combined model takes 9
hours and 52 minutes to run 11000 iterations on the
10621 probesets.
To see if the results are consistent we ran the model on
additional pairwise comparisons, selected to represent a
wide range of real differential expression (real fold change
ranging from 0.002 to 128). The behavior is similar for
the variability parameters λ across the experiments and
the relative bias ϕ shows the same ranking for all the com-
parisons (MAS5>RMA>dChip). Also the performance of
the methods is consistent in all the comparisons with the
combined method showing the highest specificity and
sensitivity. The results are presented in Tables 1, 2, 3 of
Additional file 1.
Biological example: High Fat Diet versus Normal Fat Diet 
in mice adipose tissue
There are many studies in the literature describing the
effect of high fat diet on gene expression of several tissues
in mice (see for example [42] and [43] for adipose tissue
and [44] for liver). They are particularly interesting since
the effect of diet can trigger obesity, hypertension and be
related to major pathologies as diabetes. In order to assess
if our model leads to a more powerful analysis that
improves the biological interpretability of the results we
ran it on a publicly available experiment to study the
effect of high fat diet (HFD) versus normal fat diet (NFD)
on mice adipose tissue. The array used is mouse
Table 6: Characteristics of MAS5, RMA and dChip
Background correction Perfect Match correction Normalisation Summary
MAS5 Divide the chip in 16 regions. The lowest 2% 
is the background. Weighted average over all 
the regions.
Ideal Mismatch Scaling 1 step Tukey Biweight
RMA Global model for the distribution of the probe 
intensities
No correction Quantile Median Polish
dChip No correction No correction Invariant set using one array as default Multi-chip linear model
Characteristics of MAS5, RMA and dChip in terms of perfect match correction, normalization and summarization method.
Table 7: Values of the parameters for the 5 pre-processing 
methods in the simulation scenario 
Method 1 Method 2 Method 3 Method 4 Method 5
exp(λj)1 0 . 5 0 . 5 2 2
ϕj 1 0.5 2 0.5 2BMC Bioinformatics 2008, 9:512 http://www.biomedcentral.com/1471-2105/9/512
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MG_U74Av2 and contains 12488 probesets. The experi-
ment analyzes the strain 129 and for each condition there
are 4 replicates. The .CEL files and the description of the
experiments are available at the DGAP project website
[29].
Again we pre-processed the data using MAS5, RMA and
dChip and ran the combined model, but also treated sep-
arately each pre-processing method. The MCMC estima-
tion was performed with two chains (we checked
convergence for 10000 iterations and then extracted a
sample of 1000 iterations. The MC error is smaller than
the 5% of the sample standard deviation as recom-
mended). The MCMC simulation for the combined
model takes 12 hours and 10 minutes to run 11000 itera-
tions on the 12488 probesets.
Implementation
The standard model built by equations (1), (3), (4) and
by the prior distributions has been implemented in the
free software WinBUGS and the code is provided in Addi-
tional file 1. All the analyses were performed on a DELL
Precision workstation with 3.20 GHz and 2 GB of RAM.
Note that it is relatively quick to run with a small number
of genes (it takes around 5 minutes to perform 1000 iter-
ations for 1000 genes, 2 conditions, 3 pre-processing and
5 replicates), but the time increases linearly with the
number of genes. To increase the speed on the Latin
Square data set (that includes 22300 probesets), we fil-
tered the present probesets for at least one condition,
using the present/absent call implemented in the Affy R
package; this halved the computational time (from 20 to
around 10 hours for 11000 iterations). If needed it is pos-
sible to apply different or more stringent criteria (e.g.
selecting the most variable genes between the two condi-
tions), as long as the non differentially expressed genes are
well represented in the subset, otherwise the null distribu-
tion of δg, and in particular its variability, is not properly
identified and it can affect the correct estimate of the tail
posterior probability.
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